About the Authors
- Iana H. Haralambieva
-
Affiliations Vaccine Research Group, Mayo Clinic, Rochester, Minnesota, United States of America, Program in Translational Immunovirology and Biodefense, Mayo Clinic, Rochester, Minnesota, United States of America
- Ann L. Oberg
-
Affiliation Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America
- Inna G. Ovsyannikova
-
Affiliations Vaccine Research Group, Mayo Clinic, Rochester, Minnesota, United States of America, Program in Translational Immunovirology and Biodefense, Mayo Clinic, Rochester, Minnesota, United States of America
- Richard B. Kennedy
-
Affiliations Vaccine Research Group, Mayo Clinic, Rochester, Minnesota, United States of America, Program in Translational Immunovirology and Biodefense, Mayo Clinic, Rochester, Minnesota, United States of America
- Diane E. Grill
-
Affiliation Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America
- Sumit Middha
-
Affiliation Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America
- Brian M. Bot
-
Affiliation Sage Bionetworks, Seattle, Washington, United States of America
- Vivian W. Wang
-
Affiliation Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America
- David I. Smith
-
Affiliation Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America
- Robert M. Jacobson
-
Affiliations Vaccine Research Group, Mayo Clinic, Rochester, Minnesota, United States of America, Program in Translational Immunovirology and Biodefense, Mayo Clinic, Rochester, Minnesota, United States of America, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
- Gregory A. Poland
-
* E-mail: poland.gregory@mayo.edu
Affiliations Vaccine Research Group, Mayo Clinic, Rochester, Minnesota, United States of America, Program in Translational Immunovirology and Biodefense, Mayo Clinic, Rochester, Minnesota, United States of America, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
Competing Interests
Dr. GAP is the chair of a Safety Evaluation Committee for investigational vaccine trials being conducted by Merck Research Laboratories. Dr. GAP offers consultative advice on vaccine development to Merck & Co. Inc., CSL Biotherapies, Avianax, Sanofi Pasteur, Dynavax, Novartis Vaccines and Therapeutics, and PAXVAX Inc. Dr. RMJ is a member of a Data Monitoring Committee for two Merck vaccine studies as well as a Safety Review Committee for another Merck vaccine study. He also recently served as a principal investigator for three vaccine studies including one by Novartis and two by Pfizer. BMB is employed by Sage Bionetworks, which is a commercial company. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: IHH ALO IGO RBK DEG DIS RMJ GAP. Performed the experiments: IHH IGO RBK. Analyzed the data: IHH ALO RBK DEG SM BMB VWW DIS GAP. Wrote the paper: IHH ALO IGO RBK DEG SM BMB VWW DIS RMJ GAP.